GlassScriptPhysician profile
Andre Owen Dixon
NPI 1649634486
$16,415.47
in general payments reported to CMS, 2019-2025
93 companies · $3,561 in 2025
The $3,561 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.34 · 2020: $99.95 · 2021: $1,231 · 2022: $3,849 · 2023: $3,628 · 2024: $4,020 · 2025: $3,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,832.02 |
| Education | $376.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,047.35 | 2021-2025 | |
| Janssen Biotech, INC. | $955.60 | 2021-2025 | Rybrevant, Erleada, Darzalex |
| Dendreon Pharmaceuticals LLC | $896.24 | 2021-2025 | Provenge |
| Merck Sharp & Dohme LLC | $837.94 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $746.16 | 2021-2025 | Enhertu, Datroway, Injectafer |
| Pfizer INC. | $722.14 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $619.10 | 2021-2025 | Enhertu, Tagrisso, Lynparza |
| Celgene Corporation | $576.87 | 2021-2025 | Reblozyl, Pomalyst, Opdualag |
| Glaxosmithkline, LLC. | $450.33 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| E.R. Squibb & Sons, L.L.C. | $442.30 | 2021-2025 | Opdivo, Opdualag, Krazati |
| Eisai INC. | $381.10 | 2021-2025 | |
| Lilly USA, LLC | $368.54 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Amgen INC. | $357.08 | 2019-2025 | Lumakras, Evenity, Prolia |
| Genzyme Corporation | $351.39 | 2021-2025 | |
| Abbvie INC. | $349.23 | 2021-2025 | Venclexta |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $311.74 | 2021-2025 | Trodelvy |
| Genentech USA, INC. | $277.48 | 2021-2025 | Tecentriq, Polivy, Phesgo |
| Seagen INC. | $268.24 | 2020-2023 | Tukysa, Adcetris |
| Incyte Corporation | $249.47 | 2021-2025 | Jakafi |
| Takeda Pharmaceuticals U.S.A., INC. | $234.90 | 2021-2025 | Ninlaro, Iclusig, Alunbrig |
| Servier Pharmaceuticals LLC | $222.88 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.56 | 2021-2025 | Gilotrif |
| Sobi, INC | $215.15 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $209.56 | 2023-2025 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $195.95 | 2022-2025 | Monoferric, Cosela |
| Pharmacyclics LLC, An Abbvie Company | $183.97 | 2021-2023 | Imbruvica |
| Exelixis INC. | $182.00 | 2021-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $180.21 | 2021-2024 | Libtayo |
| Adaptive Biotechnologies Corporation | $176.52 | 2023-2025 | Clonoseq |
| Aveo Pharmaceuticals, INC. | $174.37 | 2023-2025 | Fotivda |
| Astellas Pharma US INC | $165.26 | 2021-2025 | Xtandi, Xospata, Padcev |
| Puma Biotechnology, INC. | $160.95 | 2021-2025 | Nerlynx |
| Array Biopharma INC | $149.28 | 2023-2025 | Mektovi, Braftovi, Lorbrena |
| Rigel Pharmaceuticals, INC. | $142.52 | 2021-2024 | Rezlidhia, Tavalisse |
| Pharmaessentia USA Corporation | $137.07 | 2022-2025 | Besremi |
| Asd Specialty Healthcare, LLC | $131.61 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.68 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $123.90 | 2022-2024 | Xarelto |
| Karyopharm Therapeutics INC. | $123.89 | 2022-2025 | Xpovio |
| Cumberland Pharmaceuticals, INC. | $122.36 | 2023-2025 | Sancuso |
| Jazz Pharmaceuticals INC. | $114.51 | 2022-2025 | |
| Beigene USA, INC. | $101.64 | 2022-2025 | Brukinsa |
| Coherus Oncology, INC. | $99.99 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2022 | |
| Emd Serono, INC. | $91.88 | 2021-2025 | Bavencio |
| Novocure INC. | $90.42 | 2025 | Optune Lua (Novottf-200t) |
| Taiho Oncology, INC. | $89.84 | 2022-2025 | |
| Cti Biopharma Corp. | $87.30 | 2022-2023 | Vonjo |
| Epizyme, INC. | $86.20 | 2022-2025 | Tazverik |
| Tersera Therapeutics LLC | $83.45 | 2021-2025 | Xermelo, Quzyttir, Zoladex |
| Genmab U.S., INC. | $83.21 | 2022-2025 | Tivdak, Epkinly |
| Morphosys, US INC. | $77.24 | 2021-2023 | Monjuvi |
| Spectrum Pharmaceuticals INC. | $72.15 | 2024-2025 | Rolvedon |
| G1 Therapeutics, INC. | $69.72 | 2022 | |
| Azurity Pharmaceuticals, INC. | $67.95 | 2024-2025 | Vivimusta, Danziten |
| Beone Medicines USA, INC. | $65.15 | 2025 | Tevimbra |
| Adc Therapeutics America, INC. | $64.97 | 2022-2025 | |
| Mirati Therapeutics, INC. | $63.98 | 2023-2024 | Krazati |
| Stemline Therapeutics INC. | $63.81 | 2023-2025 | Orserdu |
| Ipsen Biopharmaceuticals, INC | $58.88 | 2021-2024 | Onivyde, Somatuline Depot |
| Geron Corporation | $57.73 | 2025 | Rytelo |
| Sun Pharmaceutical Industries INC. | $57.07 | 2023 | Yonsa |
| Acrotech Biopharma INC. | $54.19 | 2021-2025 | Beleodaq |
| Organon LLC | $47.17 | 2022-2023 | Ontruzant |
| Springworks Therapeutics, INC. | $46.01 | 2024-2025 | Ogsiveo, Gomekli |
| Tempus Ai, INC | $44.44 | 2025 | Xt Cdx |
| Kyowa Kirin, INC. | $42.80 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $42.00 | 2023 | Givlaari |
| Fresenius Kabi USA, LLC | $41.59 | 2025 | Stimufend |
| Deciphera Pharmaceuticals INC. | $40.45 | 2023-2024 | Qinlock |
| Tg Therapeutics, INC. | $35.34 | 2021-2022 | |
| Kite Pharma, INC. | $34.33 | 2023 | Yescarta |
| Macrogenics, INC. | $32.52 | 2021-2022 | |
| Immunogen, INC. | $31.98 | 2023-2024 | Elahere, Elahere |
| Sumitomo Pharma America, INC. | $31.31 | 2024-2025 | Orgovyx |
| Celltrion USA INC. | $30.41 | 2023-2024 | Vegzelma |
| Iovance Biotherapeutics, INC. | $29.59 | 2025 | Amtagvi |
| Blueprint Medicines Corporation | $28.06 | 2023 | Ayvakit |
| Amneal Pharmaceuticals LLC | $24.50 | 2023 | Avastin |
| Argenx US, INC. | $23.46 | 2022 | |
| Accord Healthcare, INC. | $23.37 | 2025 | |
| Hologic Sales and Service, LLC | $22.59 | 2024 | Localizer, Trident Specimen Radiography System |
| Global Blood Therapeutics, INC. | $21.78 | 2022 | |
| Agios Pharmaceuticals, INC. | $21.09 | 2022 | |
| Sirtex Medical INC | $18.20 | 2022 | |
| Syndax Pharmaceuticals, INC. | $18.10 | 2025 | |
| Caris Mpi, INC. | $14.94 | 2025 | Mi Cancer Seek |
| Blue Earth Diagnostics | $14.41 | 2022 | |
| Myovant Sciences INC. | $14.15 | 2021 | |
| Foundation Medicine, INC. | $13.78 | 2023 | Foundationone Cdx |
| Mylan Institutional INC. | $13.53 | 2022 | |
| Eusa Pharma (US) LLC | $12.98 | 2022 | |
| Myriad Genetic Laboratories, INC. | $11.47 | 2022 |
Drugs and devices associated with these payments
Provenge $666Enhertu $623Keytruda $622Rybrevant $309Imbruvica $301Opdivo $256Xtandi $244Lenvima $242Ultomiris $210Reblozyl $205Tukysa $200Talzenna $198Verzenio $190Kisqali $182Clonoseq $177Fotivda $174Lynparza $174Erleada $155Jemperli $153Zejula $153Mektovi $149Braftovi $149Orgovyx $144Trodelvy $139Monoferric $136Ojjaara $129Sancuso $122Vonjo $120Libtayo $114Jaypirca $113Ibrance $112Darzalex $111Xarelto $110Ninlaro $109Besremi $106Xpovio $105Venclexta $100Epkinly $99.51Sarclisa $92.91Krazati $91.97Optune Lua (Novottf-200t) $90.42Lutathera $89.07Elrexfio $88.87Pluvicto $87.39Scemblix $86.47Inlyta $85.30Pomalyst $84.29Jakafi $83.03Eliquis $81.34Zepzelca $80.33Tabrecta $80.11Cabometyx $78.96Tecvayli $76.80Brukinsa $76.79Opdualag $75.75Tagrisso $75.53Elahere $75.42Gilotrif $74.27Adcetris $72.53Rolvedon $72.15Udenyca $70.11Vivimusta $67.95Lorbrena $67.88Bosulif $67.28Tibsovo $66.68Tevimbra $65.15Tavalisse $64.33Rezlidhia $64.33Orserdu $63.81Paxlovid $62.10Nubeqa $61.33Voranigo $59.73Nerlynx $59.22Rytelo $57.73Yonsa $57.07Talvey $56.98Fabhalta $56.49Tazverik $55.00Welireg $51.89Lumakras $51.04Datroway $49.51Tecentriq $48.65Carvykti $47.43Lonsurf $47.35Inqovi $47.35Onivyde $47.34Tivdak $46.56Cosela $46.20Comirnaty $44.56Xt Cdx $44.44Givlaari $42.00Polivy $41.75Jevtana $41.13Retevmo $40.73Qinlock $40.45Doptelet $39.99Padcev $38.31Xermelo $37.60Bavencio $37.32Promacta $36.84
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.